| News

Roivant Sciences to join BaseLaunch Accelerator as Healthcare Partner

18.01.2018

Roivant becomes the fifth healthcare partner of BaselArea.swiss accelerator program joining Johnson & Johnson Innovation, Novartis Venture Fund, Pfizer and Roche.

BaseLaunch Teams
BaseLaunch Teams (img: Mathias Mangold)

BaseLaunch provides promising startups with access to non-dilutive funding, industry access, expert knowledge and infrastructure, and integrates them into one of the most dynamic biotech and healthcare ecosystems in Europe. The program is initiated and operated by BaselArea.swiss.

In addition to Roivant, the BaseLaunch healthcare accelerator is backed by Johnson & Johnson Innovation, Novartis Venture Fund, Pfizer, Roche and other public and private partners. Sascha Bucher, VP and Head of Global Transactions at Roivant and a senior business development and M&A professional with more than 20 years of experience, will join the BaseLaunch Selection Committee.

For Vivek Ramaswamy, Founder and CEO of Roivant, partnering with BaseLaunch underlines the company’s commitment to Basel as a central hub for pharmaceutical innovation in Europe: “Joining the accelerator will allow us to support young and talented entrepreneurs developing promising ideas, and is representative of our desire to become an integral part of the broader life science ecosystem in Basel.”

Alethia de León, Managing Director of BaseLaunch, welcomes Roivant as a Healthcare Partner of BaseLaunch: “We are very excited to have Roivant as a hands-on partner to support and help select promising healthcare startups. Their commitment to our accelerator here in Basel further adds to the strong commitment to this initiative from the leading and highly innovative corporate partners in the healthcare space.”

“Having the world’s leading healthcare companies onboard demonstrates the unique setting of the Basel region as a center for the life sciences,” says Christof Klöpper, CEO of BaselArea.swiss.

In 2017, over 100 projects applied and 11 teams were accepted into BaseLaunch. During the first three months of the program, company founders worked closely with the BaseLaunch team and a network of seasoned professionals to solidify strategy, R&D plans and operations. The companies that were selected for the next phase will be announced shortly.

Applications for 2018 are now open. For more information, visit www.baselaunch.ch

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Roche launches new coronavirus antibody test
Basel Area Business & Innovation, Innovation, Invest

Roche launches new coronavirus antibody test

Roche is launching on the market a new antibody test to determine coronavirus infections. This should help with the development...

Read More
Investors see great potential in Polyneuron
Basel Area Business & Innovation, Innovation, Invest

Investors see great potential in Polyneuron

The Basel-based company Polyneuron Pharmaceuticals extended its Series A funding round and has now raised a total of 36.5 million...

Read More
Lonza set to manufacture coronavirus drug for Humanigen
Basel Area Business & Innovation, Innovation, Invest

Lonza set to manufacture coronavirus drug for Humanigen

The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonza...

Read More
Startups from the Basel Area ranked among the best
Basel Area Business & Innovation, Innovation, Switzerland Innovation Park

Startups from the Basel Area ranked among the best

Startups from the Basel Area have been ranked highly in the TOP 100 Swiss Startup Award by Venturelab. The medtech...

Read More
Roche testing for coronavirus and flu simultaneously
Basel Area Business & Innovation, Innovation, Invest

Roche testing for coronavirus and flu simultaneously

The U.S. Food and Drug Administration has given the Basel-based life sciences company Roche authorization to use a test that...

Read More
Hengrui Medicine sets up clinical research and development in Basel
Basel Area Business & Innovation, Innovation, Invest

Hengrui Medicine sets up clinical research and development in Basel

The Chinese life sciences company Hengrui Medicine is establishing a Swiss subsidiary in Basel. The European hub for clinical research...

Read More
Polyphor awarded exclusive licensing agreement for China
Basel Area Business & Innovation, Innovation, Invest

Polyphor awarded exclusive licensing agreement for China

The Basel Area-based company Polyphor has signed an exclusive licensing agreement with Fosun Pharma in China. Fosun Pharma will lead...

Read More
New label guarantees that data remains in Switzerland
Basel Area Business & Innovation, Innovation, Invest

New label guarantees that data remains in Switzerland

With the new “swiss hosting” label, the Basel-based company swiss made software Gmbh is guaranteeing that data will not be...

Read More
Coworking in the Basel Area – An Interview with Karin Crisanto
Basel Area Business & Innovation, Switzerland Innovation Park

Coworking in the Basel Area – An Interview with Karin Crisanto

Karin Crisanto recently joined Basel Area Business & Innovation as Head of Innovation Space and Infrastructure. She previously worked for...

Read More
Switzerland ranked in second place globally
Basel Area Business & Innovation, Invest

Switzerland ranked in second place globally

The chemical and pharmaceutical industry of Switzerland has been ranked number two in the world after the USA in terms...

Read More
1 2 3 21

Do you have a question? We'd like to hear from you.